These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 30027640)
1. Reversible cholinesterase inhibitors as pretreatment for exposure to organophosphates. A review. Lorke DE; Petroianu GA J Appl Toxicol; 2019 Jan; 39(1):101-116. PubMed ID: 30027640 [TBL] [Abstract][Full Text] [Related]
2. Prophylactic administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using terbufos sulfone. Lorke DE; Nurulain SM; Hasan MY; Kuča K; Petroianu GA J Appl Toxicol; 2014 Oct; 34(10):1096-103. PubMed ID: 24136594 [TBL] [Abstract][Full Text] [Related]
3. Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors. Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Kuča K; Petroianu GA J Appl Toxicol; 2011 Aug; 31(6):515-23. PubMed ID: 20981864 [TBL] [Abstract][Full Text] [Related]
4. Acetylcholinesterase inhibitors as pretreatment before acute exposure to organophosphates: assessment using methyl-paraoxon. Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Kuča K; Petroianu GA CNS Neurol Disord Drug Targets; 2012 Dec; 11(8):1052-60. PubMed ID: 23244429 [TBL] [Abstract][Full Text] [Related]
5. Usefulness of administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using paraoxon. Petroianu GA; Nurulain SM; Shafiullah M; Hasan MY; Kuča K; Lorke DE J Appl Toxicol; 2013 Sep; 33(9):894-900. PubMed ID: 22611016 [TBL] [Abstract][Full Text] [Related]
6. Combined Pre- and Posttreatment of Paraoxon Exposure. Lorke DE; Nurulain SM; Hasan MY; Kuča K; Petroianu GA Molecules; 2020 Mar; 25(7):. PubMed ID: 32230733 [TBL] [Abstract][Full Text] [Related]
7. Reversible cholinesterase inhibitors as pre-treatment for exposure to organophosphates: assessment using azinphos-methyl. Petroianu GA; Nurulain SM; Hasan MY; Kuča K; Lorke DE J Appl Toxicol; 2015 May; 35(5):493-9. PubMed ID: 25186309 [TBL] [Abstract][Full Text] [Related]
8. Optimal Pre-treatment for Acute Exposure to the Organophosphate Dicrotophos. Lorke DE; Nurulain SM; Hasan MY; Kuca K; Petroianu GA Curr Pharm Des; 2017; 23(23):3432-3439. PubMed ID: 27799040 [TBL] [Abstract][Full Text] [Related]
9. The Experimental Oxime K027-A Promising Protector From Organophosphate Pesticide Poisoning. A Review Comparing K027, K048, Pralidoxime, and Obidoxime. Lorke DE; Petroianu GA Front Neurosci; 2019; 13():427. PubMed ID: 31191210 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic potential of memantine against soman poisoning in rats. Stojiljković MP; Škrbić R; Jokanović M; Bokonjić D; Kilibarda V; Vulović M Toxicology; 2019 Mar; 416():62-74. PubMed ID: 30682440 [TBL] [Abstract][Full Text] [Related]
11. Experimental and Established Oximes as Pretreatment before Acute Exposure to Azinphos-Methyl. Lorke DE; Nurulain SM; Hasan MY; Kuča K; Petroianu GA Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802843 [TBL] [Abstract][Full Text] [Related]
12. Oximes as pretreatment before acute exposure to paraoxon. Lorke DE; Nurulain SM; Hasan MY; Kuča K; Petroianu GA J Appl Toxicol; 2019 Nov; 39(11):1506-1515. PubMed ID: 31264735 [TBL] [Abstract][Full Text] [Related]
13. In silico and in vitro evaluation of two novel oximes (K378 and K727) in comparison to K-27 and pralidoxime against paraoxon-ethyl intoxication. Arshad M; Fatmi MQ; Musilek K; Hussain A; Kuca K; Petroianu G; Kalasz H; Nurulain SM Toxicol Mech Methods; 2018 Jan; 28(1):62-68. PubMed ID: 28722512 [TBL] [Abstract][Full Text] [Related]
14. Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: tiapride vs. pyridostigmine. Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Sheen R; Nagelkerke N Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):235-40. PubMed ID: 17056080 [TBL] [Abstract][Full Text] [Related]
15. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds. Eckert S; Eyer P; Mückter H; Worek F Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806 [TBL] [Abstract][Full Text] [Related]
16. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon. Petroianu GA; Arafat K; Kuca K; Kassa J J Appl Toxicol; 2006; 26(1):64-71. PubMed ID: 16193529 [TBL] [Abstract][Full Text] [Related]
17. Protective drugs in acute large-dose exposure to organophosphates: a comparison of metoclopramide and tiapride with pralidoxime in rats. Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Sheen R; Saleh A; Schmitt A Anesth Analg; 2005 Feb; 100(2):382-386. PubMed ID: 15673862 [TBL] [Abstract][Full Text] [Related]
18. The role of oximes in the treatment of nerve agent poisoning in civilian casualties. Marrs TC; Rice P; Vale JA Toxicol Rev; 2006; 25(4):297-323. PubMed ID: 17288500 [TBL] [Abstract][Full Text] [Related]
19. Slow-binding reversible inhibitor of acetylcholinesterase with long-lasting action for prophylaxis of organophosphate poisoning. Lenina OA; Zueva IV; Zobov VV; Semenov VE; Masson P; Petrov KA Sci Rep; 2020 Oct; 10(1):16611. PubMed ID: 33024231 [TBL] [Abstract][Full Text] [Related]
20. Reactivation of organophosphate-inhibited human AChE by combinations of obidoxime and HI 6 in vitro. Worek F; Aurbek N; Thiermann H J Appl Toxicol; 2007; 27(6):582-8. PubMed ID: 17370251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]